Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by national cholesterol education program risk category

Adam B. Polis, Nicola Abate, Alberico L. Catapano, Christie M. Ballantyne, Michael H. Davidson, Steven S. Smugar, Andrew M. Tershakovec

Research output: Contribution to journalArticle

6 Scopus citations

Fingerprint Dive into the research topics of 'Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by national cholesterol education program risk category'. Together they form a unique fingerprint.

Medicine & Life Sciences